Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer (CYT-500)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2007 by Cytogen Corporation.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Cytogen Corporation
ClinicalTrials.gov Identifier:
NCT00441571
First received: February 27, 2007
Last updated: September 6, 2007
Last verified: September 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given